FMR LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 13,957,269 15.000% | 4,325,631 (+44.91%) | Filing |
| 2025-02-07 10:23 am Purchase | 2025-01-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 9,631,638 10.400% | 727,552 (+8.17%) | Filing |
| 2025-02-07 10:06 am Purchase | 2024-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 8,904,086 9.600% | 4,860,221 (+120.19%) | Filing |
| 2024-02-09 08:50 am Purchase | 2024-02-08 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 4,043,865 6.053% | 2,160,747 (+114.74%) | Filing |
| 2023-02-09 09:59 am Sale | 2023-02-09 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 1,883,118 3.499% | -1,839,176 (-49.41%) | Filing |
| 2022-01-10 1:26 pm Sale | 2022-01-07 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 3,722,294 7.836% | -1,216,055 (-24.62%) | Filing |